(Q46245723)

20 December 2017

title

Patient-reported cognitive side effects of antiepileptic drugs: predictors and comparison of all commonly used antiepileptic drugs (English)

1 reference

20 December 2017

1 reference

Lawrence James Hirsch

6

object named as

Lawrence J Hirsch

1 reference

20 December 2017

author name string

Hiba Arif

1

1 reference

20 December 2017

Richard Buchsbaum

2

1 reference

20 December 2017

David Weintraub

3

1 reference

20 December 2017

Joanna Pierro

4

1 reference

20 December 2017

Stanley R Resor

5

1 reference

20 December 2017

publication date

17 December 2008

1 reference

20 December 2017

published in

Epilepsy Behavior

1 reference

20 December 2017

volume

14

1 reference

20 December 2017

issue

1

1 reference

20 December 2017

page(s)

202-209

1 reference

20 December 2017

Cognitive and memory effects of the new antiepileptic drugs

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.017

Optimizing health outcomes in active epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.017

Phenytoin and carbamazepine: differential effects on cognitive function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.017

A Systematic Review of the Effects of Lamotrigine on Cognitive Function and Quality of Life

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.017

Newer antiepileptic drugs and cognitive issues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.017

Cognitive side effects of antiepileptic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.017

A comparative study of the cognitive effects of phenytoin and carbamazepine in new referrals with epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.017

Effects of removal of phenytoin, carbamazepine, and valproate on cognitive function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.017

Carbamazepine and phenytoin. Comparison of cognitive effects in epileptic patients during monotherapy and withdrawal.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.017

Cognitive function in adult epileptic patients established on anticonvulsant monotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.017

Carbamazepine plasma concentration. Relationship to cognitive impairment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.017

Improvement in cognitive functioning and mood state after conversion to valproate monotherapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.017

Do antiepileptic drugs accelerate forgetting?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.017

Neuropsychological effects of carbamazepine and phenytoin: a reanalysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.017

Comparative cognitive effects of carbamazepine and phenytoin in healthy adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.017

Comparative cognitive effects of anticonvulsants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.017

Differential cognitive and behavioral effects of topiramate and valproate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.017

Neuropsychiatric profiles of patients with juvenile myoclonic epilepsy treated with valproate or topiramate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.017

Effect of topiramate on attention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.017

The influence of antiepileptic drugs on cognition: a comparison of levetiracetam with topiramate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.017

Long-term cognitive and mood effects of zonisamide monotherapy in epilepsy patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.017

A multicenter, randomized clinical study to evaluate the effect on cognitive function of topiramate compared with valproate as add-on therapy to carbamazepine in patients with partial-onset seizures.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.017

Efficacy and cognitive side effects of tiagabine and topiramate in patients with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.017

Cognitive profile of topiramate as compared with lamotrigine in epilepsy patients on antiepileptic drug polytherapy: relationships to blood serum levels and comedication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.017

Topiramate in the prophylactic treatment of cluster headache

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.017

The effects of adjunctive topiramate on cognitive function in patients with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.017

Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.017

Topiramate in migraine prophylaxis: a randomised double-blind versus placebo study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.017

Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1,000-mg daily dosages. Topiramate YE Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.017

Effects of topiramate and gabapentin on cognitive abilities in healthy volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.017

Postmarketing experience with topiramate and cognition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.017

Effects of topiramate on cognitive function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.017

Cognitive and behavioral effects of lamotrigine and topiramate in healthy volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.017

The Effect of Antiepileptic Drugs on Cognition: Patient Perceived Cognitive Problems of Topiramate versus Levetiracetam in Clinical Practice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.017

New antiepileptic drugs: comparison of key clinical trials.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.017

Topiramate for the treatment of epilepsy and other nervous system disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.017

Topiramate for migraine prevention: a randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.017

Topiramate in migraine prevention: results of a large controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.017

Language Disturbances as Side Effects of Topiramate and Zonisamide Therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.017

Gabapentin and cognition: a double blind, dose ranging, placebo controlled study in refractory epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.017

Cognitive effects of a new pyrrolidine derivative (levetiracetam) in patients with epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.017

Adverse reactions to new anticonvulsant drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.017

Cognitive effects of lamotrigine compared with topiramate in patients with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.017

Vigabatrin vs carbamazepine monotherapy in patients with newly diagnosed epilepsy. A randomized, controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.017

Safety and efficacy of vigabatrin and carbamazepine in newly diagnosed epilepsy: a multicentre randomised double-blind study. Vigabatrin European Monotherapy Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.017

Cognitive effects of oxcarbazepine and phenytoin monotherapy in newly diagnosed epilepsy: one year follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.017

Cognitive and quality of life effects of differing dosages of tiagabine in epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.017

Long-term cognitive and EEG effects of tiagabine in drug-resistant partial epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.017

A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.017

Effects of carbamazepine and phenytoin on EEG and memory in healthy adults.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.017

Antiepileptic drugs and memory

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.017

Differential cognitive effects of carbamazepine and gabapentin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.017

Topiramate and word-finding difficulties in patients with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.017

Psychiatric and behavioral side effects of the newer antiepileptic drugs in adults with epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.017

Cognitive side effects of antiepileptic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.017

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YEBEH.2008.10.017

1 reference

20 December 2017

1 reference

20 December 2017